XJO 0.88% 7,959.3 s&p/asx 200

Thursday, 30 April - An Apetite for Risk, page-6

  1. 977 Posts.
    lightbulb Created with Sketch. 32
    FYI:
    Preliminary results indicate that patients who received remdesivir had a 31% faster time to recovery than those who received placebo (p < 0.001). Specifically, the median time to recovery was 11 days for patients treated with remdesivir compared with 15 days for those who received placebo. Results also suggested a survival benefit, with a mortality rate of 8.0% for the group receiving remdesivir versus 11.6% for the placebo group (p=0.059).
 
watchlist Created with Sketch. Add XJO (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.